The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Open accessAbstract
Spike (S) proteins of coronaviruses, including the coronavirus that causes severe acute respiratory syndrome (SARS), associate with cellular receptors to mediate infection of their target cells. Here we identify a metallopeptidase, angiotensin-converting enzyme 2 (ACE2), isolated from SARS coronavirus (SARS-CoV)-permissive Vero E6 cells, that efficiently binds the S1 domain of the SARS-CoV S protein. We found that a soluble form of ACE2, but not of the related enzyme ACE1, blocked association of the S1 domain with Vero E6 cells. 293T cells transfected with ACE2, but not those transfected with human immunodeficiency virus-1 receptors, formed multinucleated syncytia with cells expressing S protein. Furthermore, SARS-CoV replicated efficiently on ACE2-transfected but not mock-transfected 293T cells. Finally, anti-ACE2 but not anti-ACE1 antibody blocked viral replication on Vero E6 cells. Together our data indicate that ACE2 is a functional receptor for SARS-CoV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, ACE2 (angiotensin-converting enzyme 2) had been identified as the receptor for SARS-CoV 4,5 and SARS-CoV-2.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [5]
In the citing paper
“Study of Zhou et al.4 indicated that the angiotensin-converting enzyme II (ACE2) is likely the cell receptor of 2019-nCoV, which were also the receptor for SARS-CoV and HCoV-NL637,8.”
From High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa (2020) · cites this paper as [7]
In the citing paper
“The cell surface receptor for the CoV-1 and CoV-2 surface spike protein has been identified by affinity-MS to be angiotensin-converting enzyme 2 (ACE2)147”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [147]
In the citing paper
“As an alternative approach, cellular interaction partners for a single viral protein of interest have also been investigated by in vitro incubation of the viral protein bait with lysates from uninfected permissive cells.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“while promoted upon ACE2 overexpression in HEK293T cells that are otherwise non-permissive to SARS-CoV.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“which was further functionally characterized as a functional receptor for SARS-CoV.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“MS analysis revealed the cellular metallopeptidase angiotensin-converting enzyme 2 (ACE2) as an S1 interaction partner”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“Viral replication was inhibited upon incubation with antibodies against ACE2”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“This interaction requires cleavage of the S protein, likely by the cell surface protease TMPRSS2, although other proteases (such as Cathepsin B and L, CTSB/CTSL) may also be involved (4-6, 22-25).”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [23]
In the citing paper
“CoV-2 — like SARS-CoV — infects cells through interactions between its spike (S) protein and the ACE2 protein on target cells.”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [23]
In the citing paper
“ACE2 is the functional entry receptor for both severe acute respiratory syndrome (SARS) coronaviruses, SARS-CoV (36) and SARS-CoV-2 (37).”
From TCRD and pharos 2021: mining the human proteome for disease biology (2021) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R. P., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,477
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Choe, H., Farzan, M., Sun, Y., Sullivan, N. J., Rollins, B. J., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G. J., Newman, W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81313-6 · Cited by 2,286
Self-citationA Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E. H., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,041
The Genome Sequence of the SARS-Associated Coronavirus
Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A. R., Butterfield, Y. S. N., Khattra, J. S., Asano, J. K., Barber, S., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,027
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V. K., Dick, L. R., Gavin, J. M., Tang, J., Godbout, K., Parsons, T. F., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,406
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
Kuiken, T., Fouchier, R. A. M., Schutten, M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D. A. J., Laman, J. D., de Jong, T., van Doornum, G., Lim, W. W. L., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13967-0 · Cited by 1,015
Cited by
Sorted by citations
Items 701–800 of 1,026
Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections
Okabayashi, T., Kariwa, H., Yokota, S.-I., Iki, S., Indoh, T., Yokosawa, N., Takashima, I., Tsutsumi, H., & Fujii, N. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20556 · Cited by 146
A comparative overview of COVID-19, MERS and SARS: Review article
Liu, J., Xie, W., Wang, Y., Xiong, Y., Chen, S., Han, J., & Wu, Q. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.07.032 · Cited by 146
COVID-19 and the Kidneys: An Update
Benedetti, C., Waldman, M. A., Zaza, G., Riella, L. V., & Cravedi, P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00423 · Cited by 145
Role of Hypertension on the Severity of COVID-19: A Review
Peng, M., He, J., Xue, Y., Xue, Y., Liu, S., & Gong, Z. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001116 · Cited by 147
Expression cloning of functional receptor used by SARS coronavirus
Wang, P., Chen, J., Zheng, A., Nie, Y., Shi, X., Wang, W., Wang, G., Luo, M., Liu, H., Tan, L., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.076 · Cited by 146
Recent highlights in the development of new antiviral drugs
Clercq, E. D. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.08.010 · Cited by 145
Leth‐Larsen, R., Zhong, F., Chow, V. T. K., Holmskov, U., & Lu, J. (2007) · Immunobiology · doi:10.1016/j.imbio.2006.12.001 · Cited by 144
He, B., Zhang, Y., Xu, L., Yang, W., Yang, F., Feng, Y., Xia, L., Zhou, J., Zhen, W., Feng, Y., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00631-14 · Cited by 144
Sialic acid is a receptor determinant for infection of cells by avian Infectious bronchitis virus
Winter, C., Schwegmann‐Weßels, C., Cavanagh, D., Neumann, U., & Herrler, G. (2006) · Journal of General Virology · doi:10.1099/vir.0.81651-0 · Cited by 144
Zhao, G., Du, L., Ma, C., Li, Y., Li, L., Poon, V. K., Wang, L., Yu, F., Zheng, B.-J., Jiang, S., et al. (2013) · Virology Journal · doi:10.1186/1743-422x-10-266 · Cited by 144
ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models
Alenina, N. V., & Bäder, M. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2679-4 · Cited by 145
Human and novel coronavirus infections in children: a review
Rajapakse, N., & Dixit, D. (2020) · Paediatrics and International Child Health · doi:10.1080/20469047.2020.1781356 · Cited by 144
Li, Y., Wang, H., Tang, X., Fang, S., Ma, D., Du, C., Wang, Y., Pan, H., Yao, W., Zhang, R., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01283-20 · Cited by 144
Self-citationCocozza, F., Névo, N., Piovesana, E., Lahaye, X., Buchrieser, J., Schwartz, O., Manel, N., Tkach, M., Théry, C., & Jaular, L. M. (2020) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12050 · Cited by 144
Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy
Jiang, Y.-Z., Rubin, L., Peng, T., Liu, L., Xing, X., Lazarovici, P., & Zheng, W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59272 · Cited by 144
Thrombotic complications of COVID-19
Avila, J., Long, B., Holladay, D., & Gottlieb, M. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.09.065 · Cited by 143
Conformational States of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Ectodomain
Li, F., Berardi, M. J., Li, W., Farzan, M., Dormitzer, P. R., & Harrison, S. C. (2006) · Journal of Virology · doi:10.1128/jvi.02744-05 · Cited by 143
Self-citationEpidemiological analysis of COVID‐19 and practical experience from China
Ye, Q., Wang, B., Mao, J., Fu, J., Shang, S., Shu, Q., & Zhang, T. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25813 · Cited by 143
Uzunova, K. H., Filipova, E. P., Pavlova, V., & Vekov, T. Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110668 · Cited by 143
Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2
Mou, H., Quinlan, B. D., Peng, H., Liu, G., Guo, Y., Peng, S., Zhang, L., Davis-Gardner, M. E., Gardner, M. R., Crynen, G. C., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009501 · Cited by 147
Self-citationDu, L., Zhao, G., Yang, Y., Qiu, H., Wang, L., Kou, Z., Tao, X., Yu, H., Sun, S., Tseng, C.-T. K., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00433-14 · Cited by 142
He, Y., Zhou, Y., Wu, H., Luo, B., Chen, J., Li, W., & Jiang, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4050 · Cited by 142
Self-citationSchneider, M., Ackermann, K., Stuart, M. A., Wex, C. M., Protzer, U., Schätzl, H. M., & Gilch, S. (2012) · Journal of Virology · doi:10.1128/jvi.01001-12 · Cited by 142
Targeting TNF-α for COVID-19: Recent Advanced and Controversies
Guo, Y., Hu, K., Li, Y., Lu, C., Ling, K., Cai, C., Wang, W., & Ye, D. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.833967 · Cited by 143
Chen, I.-Y., Chang, S. C., Wu, H.-Y., Yu, T.-C., Wei, W.-C., Lin, S., Chien, C.-L., & Chang, M.-F. (2010) · Journal of Virology · doi:10.1128/jvi.02560-09 · Cited by 141
Song, H. C., Seo, M. Y., Stadler, K., Yoo, B. J., Choo, Q., Coates, S. R., Uematsu, Y., Harada, T., Greer, C. E., Polo, J. M., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10328-10335.2004 · Cited by 141
Cryo-Electron Microscopy Structure of Porcine Deltacoronavirus Spike Protein in the Prefusion State
Shang, J., Zheng, Y., Yang, Y., Liu, C., Geng, Q., Tai, W., Du, L., Zhou, Y., Zhang, W., & Li, F. (2017) · Journal of Virology · doi:10.1128/jvi.01556-17 · Cited by 141
Wang, B., Liu, Y., Ji, C., Yang, Y., Liang, Q., Zhao, P., Xu, L.-D., Lei, X., Luo, W.-T., Qin, P., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00318-18 · Cited by 141
Hufsky, F., Lamkiewicz, K., Almeida, A., Aouacheria, A., Arighi, C. N., Bateman, A. G., Baumbach, J., Beerenwinkel, N., Brandt, C., Cacciabue, M., et al. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa232 · Cited by 141
COVID‐19 and non‐alcoholic fatty liver disease: Two intersecting pandemics
Portincasa, P., Krawczyk, M. J., Smyk, W., Lammert, F., & Ciaula, A. D. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13338 · Cited by 141
Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins
Zhang, Y., Zhao, W., Mao, Y., Chen, Y., Wang, S., Zhong, Y., Su, T., Gong, M., Du, D., Lu, X., et al. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra120.002295 · Cited by 141
Camostat mesylate against SARS‐CoV‐2 and COVID‐19—Rationale, dosing and safety
Breining, P., Frølund, A. L., Højen, J. F., Gunst, J. D., Stærke, N. B., Sædder, E. A., Cases, M., Little, P. S., Nielsen, L. P., Søgaard, O. S., et al. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13533 · Cited by 141
Quinlan, B. D., Mou, H., Zhang, L., Guo, Y., He, W., Ojha, A., Parcells, M. S., Luo, G., Li, W., Zhong, G., et al. (2020) · doi:10.1101/2020.04.10.036418 · Cited by 140
Self-citationThe Secret Life of ACE2 as a Receptor for the SARS Virus
Dimitrov, D. S. (2003) · Cell · doi:10.1016/s0092-8674(03)00976-0 · Cited by 140
Tseng, C.-T. K., Tseng, J., Perrone, L. A., Worthy, M. N., Popov, V. L., & Peters, C. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9470-9479.2005 · Cited by 140
Yang, Y., Qin, P., Wang, B., Liu, Y., Xu, G.-H., Peng, L., Zhou, J., Zhu, S., & Huang, Y. (2019) · Journal of Virology · doi:10.1128/jvi.01448-19 · Cited by 140
Mahdavi, A. M. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2119 · Cited by 141
Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19
Choudhary, S., Sreenivasulu, K., Mitra, P., Misra, S., & Sharma, P. (2020) · Annals of Laboratory Medicine · doi:10.3343/alm.2021.41.2.129 · Cited by 140
Rattanapisit, K., Shanmugaraj, B., Manopwisedjaroen, S., Purwono, P. B., Siriwattananon, K., Khorattanakulchai, N., Hanittinan, O., Boonyayothin, W., Thitithanyanont, A., Smith, D. R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-74904-1 · Cited by 140
Day, C. W., Baric, R. S., Cai, S. X., Frieman, M. B., Kumaki, Y., Morrey, J. D., Smee, D. F., & Barnard, D. L. (2009) · Virology · doi:10.1016/j.virol.2009.09.023 · Cited by 139
Ma, C., Li, Y., Wang, L., Zhao, G., Tao, X., Tseng, C.-T. K., Zhou, Y., Du, L., & Jiang, S. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.02.004 · Cited by 139
Mossel, E. C., Huang, C., Narayanan, K., Makino, S., Tesh, R. B., & Peters, C. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3846-3850.2005 · Cited by 139
Ng, M., Ndungo, E., Kaczmarek, M. E., Herbert, A. S., Binger, T., Kuehne, A. I., Jangra, R. K., Hawkins, J. A., Gifford, R. J., Biswas, R., et al. (2015) · eLife · doi:10.7554/elife.11785 · Cited by 139
Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development
Shanmugaraj, B., Malla, A., & Phoolcharoen, W. (2020) · Pathogens · doi:10.3390/pathogens9020148 · Cited by 139
Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2
Cheng, M. P., Yansouni, C. P., Basta, N. E., Desjardins, M., Kanjilal, S., Paquette, K., Caya, C., Semret, M., Quach, C., Libman, M., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2854 · Cited by 138
Review: Roles of human serum albumin in prediction, diagnoses and treatment of COVID-19
Rabbani, G., & Ahn, S. N. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.10.095 · Cited by 139
Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection
Chan, V. S. F., Chan, K. Y. K., Chen, Y., Poon, L. L. M., Cheung, A., Zheng, B., Chan, K., Mak, W., Ngan, H., Xu, X., et al. (2005) · Nature Genetics · doi:10.1038/ng1698 · Cited by 138
Dijkman, R., Jebbink, M. F., Deijs, M., Milewska, A., Pyrć, K., Buelow, E., van der Bijl, A., & van der Hoek, L. (2012) · Journal of General Virology · doi:10.1099/vir.0.043919-0 · Cited by 138
Versteeg, G. A., van de Nes, P. S., Bredenbeek, P. J., & Spaan, W. J. M. (2007) · Journal of Virology · doi:10.1128/jvi.01033-07 · Cited by 138
Lessons from SARS: control of acute lung failure by the SARS receptor ACE2
Kuba, K., Imai, Y., Rao, S., Jiang, C., & Penninger, J. M. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0094-9 · Cited by 138
Saikatendu, K. S., Joseph, J. S., Subramanian, V., Neuman, B. W., Buchmeier, M. J., Stevens, R. C., & Kühn, P. (2007) · Journal of Virology · doi:10.1128/jvi.02236-06 · Cited by 138
Morales, D. R., Conover, M. M., You, S. C., Pratt, N. L., Kostka, K., Duarte‐Salles, T., Fernández‐Bertolín, S., Aragón, M., DuVall, S. L., Lynch, K. E., et al. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30289-2 · Cited by 138
Griffin, K. H., Fok, S. W., & Leach, J. K. (2022) · npj Regenerative Medicine · doi:10.1038/s41536-022-00266-z · Cited by 138
The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell typesPreprint
Daniloski, Z., Jordan, T. X., Ilmain, J. K., Guo, X., Bhabha, G., tenOever, B. R., & Sanjana, N. E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.14.151357 · Cited by 138
Du, L., Zhao, G., Lin, Y., Sui, H., Chan, C. C. S., Ma, S., He, Y., Jiang, S., Wu, C. Y., Yuen, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.948 · Cited by 137
Retroviral Vectors Pseudotyped with Severe Acute Respiratory Syndrome Coronavirus S Protein
Giroglou, T., Cinatl, J. J., Rabenau, H. F., Drosten, C., Schwalbe, H., Doerr, H. W., & von Laer, D. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9007-9015.2004 · Cited by 137
Wang, S., Guo, F., Liu, K., Wang, H., Rao, S., Yang, P., & Jiang, C. (2008) · Virus Research · doi:10.1016/j.virusres.2008.03.004 · Cited by 137
Jiang, S., Bottazzi, M. E., Du, L., Lustigman, S., Tseng, C.-T. K., Curti, E., Jones, K. M., Zhan, B., & Hotez, P. J. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.126 · Cited by 137
Chen, Y.-Q., Rajashankar, K. R., Yang, Y., Agnihothram, S., Liu, C., Lin, Y.-L., Baric, R. S., & Li, F. (2013) · Journal of Virology · doi:10.1128/jvi.01756-13 · Cited by 137
Therapeutic strategies for critically ill patients with COVID-19
Li, L., Li, R., Wu, Z., Yang, X., Zhao, M., Liu, J., & Chen, D. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00661-z · Cited by 137
Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management
Liu, M., Wang, T., Zhou, Y., Zhao, Y., Zhang, Y., & Li, J. (2020) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2020-0003 · Cited by 137
Severe COVID-19 and aging: are monocytes the key?
Pence, B. D. (2020) · GeroScience · doi:10.1007/s11357-020-00213-0 · Cited by 137
Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV?
Nguyen, H. L., Lan, P. D., Thai, N. Q., Nissley, D. A., O’Brien, E. P., & Li, M. S. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c04511 · Cited by 137
Zhang, Y., Chen, Y., Zhou, J. Z., Wang, X., Ma, L., Li, J., Yang, L., Yuan, H., Pang, D., & Ouyang, H. (2022) · Viruses · doi:10.3390/v14112434 · Cited by 137
Sáinz, B., Rausch, J. M., Gallaher, W. R., Garry, R. F., & Wimley, W. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.7195-7206.2005 · Cited by 137
Supramolecular Architecture of the Coronavirus Particle
Neuman, B. W., & Buchmeier, M. J. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2016.08.005 · Cited by 136
Taylor, J. K., Coleman, C. M., Postel, S., Sisk, J. M., Bernbaum, J. G., Venkataraman, T., Sundberg, E. J., & Frieman, M. B. (2015) · Journal of Virology · doi:10.1128/jvi.02274-15 · Cited by 136
Early events during human coronavirus OC43 entry to the cell
Owczarek, K., Szczepański, A., Milewska, A., Baster, Z., Rajfur, Z., Sarna, M., & Pyrć, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-25640-0 · Cited by 136
ACE2 and COVID-19 and the resulting ARDS
Zhang, X., Li, S., & Niu, S. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-137935 · Cited by 137
South, A. M., Brady, T. M., & Flynn, J. T. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15291 · Cited by 138
The immuno-oncological challenge of COVID-19
Derosa, L., Melenotte, C., Griscelli, F., Gachot, B., Marabelle, A., Kroemer, G., & Zitvogel, L. (2020) · Nature Cancer · doi:10.1038/s43018-020-00122-3 · Cited by 136
Impact of Tobacco Smoking on the Risk of COVID-19: A Large Scale Retrospective Cohort Study
Paleiron, N., Mayet, A., Marbac, V., Périsse, A., Barazzutti, H., Brocq, F.-X., Janvier, F., Dautzenberg, B., & Bylicki, O. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntab004 · Cited by 137
He, Y., Li, J., Heck, S., Lustigman, S., & Jiang, S. (2006) · Journal of Virology · doi:10.1128/jvi.00083-06 · Cited by 135
SARS corona virus peptides recognized by antibodies in the sera of convalescent cases
Guo, J. P., Petric, M., Campbell, W. J., & McGeer, P. L. (2004) · Virology · doi:10.1016/j.virol.2004.04.017 · Cited by 135
Molecular diversity of coronavirus host cell entry receptors
Millet, J. K., Jaimes, J. A., & Whittaker, G. R. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa057 · Cited by 137
Zhang, H., Wang, G., Li, J., Nie, Y., Shi, X., Lian, G., Wang, W., Yin, X., Zhao, Y., Qu, X., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.6938-6945.2004 · Cited by 135
Rockx, B., Corti, D., Donaldson, E., Sheahan, T., Stadler, K., Lanzavecchia, A., & Baric, R. (2008) · Journal of Virology · doi:10.1128/jvi.02377-07 · Cited by 134
COVID19: an announced pandemic
Platto, S., Xue, T., & Carafoli, E. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02995-9 · Cited by 134
Mapping SARS-CoV-2 antigenic relationships and serological responses
Wilks, S. H., Mühlemann, B., Shen, X., Türeli, S., LeGresley, E. B., Netzl, A., Caniza, M. A., Chacaltana-Huarcaya, J. N., Corman, V. M., Daniell, X. G., et al. (2023) · Science · doi:10.1126/science.adj0070 · Cited by 134
Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patientPreprint
Harcourt, J. L., Tamin, A., Lu, X., Kamili, S., Sakthivel, S. K., Murray, J., Queen, K. J., Tao, Y., Paden, C. R., Zhang, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.02.972935 · Cited by 134
Lew, R. A., Warner, F. J., Hanchapola, I., Yarski, M. A., Manohar, J., Burrell, L. M., & Smith, A. I. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.040352 · Cited by 133
ACE2 Cell Biology, Regulation, and Physiological Functions
Turner, A. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801364-9.00025-0 · Cited by 134
Short-term predictions and prevention strategies for COVID-19: A model-based study
Nadim, S. S., Ghosh, I., & Chattopadhyay, J. (2021) · Applied Mathematics and Computation · doi:10.1016/j.amc.2021.126251 · Cited by 133
Molecular docking analysis of rutin reveals possible inhibition of SARS-CoV-2 vital proteins
Rahman, F., Tabrez, S. S. M., Ali, R. A., Alqahtani, A. S., Ahmed, M. Z., & Rub, A. (2021) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2021.01.006 · Cited by 133
Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
Ricke, D. O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640093 · Cited by 133
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
Park, Y., Marco, A. D., Starr, T. N., Liu, Z., Pinto, D., Walls, A. C., Zatta, F., Zepeda, S. K., Bowen, J. E., Sprouse, K. R., et al. (2022) · Science · doi:10.1126/science.abm8143 · Cited by 135
Chang, Y., Liu, C. Y. Y., Chiang, B., Chao, Y., & Chen, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7602 · Cited by 132
Petit, C. M., Chouljenko, V. N., Iyer, A. V., Colgrove, R., Farzan, M., Knipe, D. M., & Kousoulas, K. G. (2006) · Virology · doi:10.1016/j.virol.2006.10.034 · Cited by 132
Self-citationFukushi, S., Mizutani, T., Saijo, M., Matsuyama, S., Miyajima, N., Taguchi, F., Itamura, S., Kurane, I., & Morikawa, S. (2005) · Journal of General Virology · doi:10.1099/vir.0.80955-0 · Cited by 132
Cagliani, R., Forni, D., Clerici, M., & Sironi, M. (2020) · Journal of Virology · doi:10.1128/jvi.00411-20 · Cited by 132
Yang, Y., Yu, J.-Q., & Huang, Y. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198024 · Cited by 132
Pandey, A., Nikam, A. N., Shreya, A. B., Mutalik, S. P., Gopalan, D., Kulkarni, S., Padya, B. S., Fernandes, G. J., Mutalik, S., & Prassl, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117883 · Cited by 132
Infectivity of human coronavirus in the brain
Cheng, Q., Yang, Y., & Gao, J. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102799 · Cited by 132
SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management
Wu, L., O’Kane, A., Hu, P., Bi, Y., Motriuk-Smith, D., & Ren, J. T. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114114 · Cited by 132
Recent progress in translational engineered in vitro models of the central nervous system
Nikolakopoulou, P., Rauti, R., Voulgaris, D., Shlomy, I., Maoz, B. M., & Herland, A. (2020) · Brain · doi:10.1093/brain/awaa268 · Cited by 133
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules
Gorshkov, K., Chen, C. Z., Bostwick, R. J., Rasmussen, L. A., Tran, B. N., Cheng, Y.-S., Xu, M., Pradhan, M., Henderson, M. J., Zhu, W., et al. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00349 · Cited by 132
V’kovski, P., Gultom, M. L., Kelly, J. N., Steiner, S., Russeil, J., Mangeat, B., Cora, E., Pezoldt, J., Holwerda, M., Kratzel, A., et al. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001158 · Cited by 132
Huang, Y., Yang, Z., Kong, W., & Nabel, G. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12557-12565.2004 · Cited by 132
Du, L., Kao, R. Y. T., Zhou, Y., He, Y., Zhao, G., Wong, C., Jiang, S., Yuen, K., Jin, D., & Zheng, B.-J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.092 · Cited by 131
Angiotensin-converting enzyme 2 in acute respiratory distress syndrome
Imai, Y., Kuba, K., & Penninger, J. M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6228-6 · Cited by 131
Metadata
- Authors
- Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., Choe, H., & Farzan, M.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Tufts University (US)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Choe, Hyeryun
- Farzan, Michael
- ORCID
- Venue
- Nature
- Published
- 2003-11-27
- Volume
- 426
- Issue
- 6965
- Pages
- 450-454
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7095016
- OpenAlex
- W1966238900
- Cited by
- 5,923
- References
- 32
- Citations by year
- 2026: 74 · 2025: 145 · 2024: 298 · 2023: 448 · 2022: 732 · 2021: 1288 · 2020: 1794 · 2019: 32 · 2018: 30 · 2017: 44 · 2016: 50 · 2015: 49 · 2014: 62 · 2013: 43 · 2012: 50
- FWCI
- 79.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Science Foundation
- National Aeronautics and Space Administration
- Hawaii Community Foundation
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- angiotensin-converting enzyme 2, SARS coronavirus, viral receptor, receptor binding, syncytium formation, viral replication, ACE1, Vero E6 cells, HEK293T cells, antibody inhibition
- MeSH terms
- Angiotensin-Converting Enzyme 2, Animals, Antibodies, Carboxypeptidases, Cell Line, Chlorocebus aethiops, Humans, Peptidyl-Dipeptidase A, Membrane Glycoproteins, Molecular Weight, Protein Binding, Receptors, Virus, Solubility, Transfection, Vero Cells, Viral Envelope Proteins, Virus Replication, Giant Cells, Protein Structure, Tertiary, Severe acute respiratory syndrome-related coronavirus, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
